Cathie Wood's ARK ETF disclosed their daily trades for Tuesday, December 3rd, 2024, with a notable shift in their investment strategy. Leading the trades was the sale of Butterfly Network Inc (NYSE:BFLY) shares, totaling 391,044 units through the ARKG ETF, amounting to $1,317,818. This move represents the largest dollar-value transaction for the day and continues a selling trend for BFLY observed over the past week.
On the buying side, ARK invested in 400,323 shares of AbSci Corp (NASDAQ:ABSI) through the ARKG ETF, with a total value of $1,261,017. This purchase marks a consistent increase in the fund's position in ABSI, adding to the previous acquisitions made last week.
The fund also continued to adjust its holdings in the biotechnology space, buying a total of 38,584 shares of Pacific Biosciences (NASDAQ:PACB) of California Inc (NASDAQ:PACB) for $74,467, which was distributed between the ARKK and ARKG ETFs. This is in line with ARK's ongoing accumulation of PACB, as seen in the recent daily trade reports.
In smaller transactions, ARK sold 171,137 shares of Repare Therapeutics Inc (NASDAQ:RPTX) through the ARKG ETF, valued at $54,838, and a total of 545 shares of Markforged Holding Corp (NYSE:MKFG) across ARKQ and ARKX (NYSE:ARKX) ETFs, with a combined value of $2,174.
Investors following Cathie Wood's ARK ETFs will note the continued focus on innovative companies, particularly in the genomics and biotech sectors, as well as the strategic adjustments made to their holdings in response to market conditions. The daily trade reports provide insight into ARK's investment strategy and the specific companies that are shaping their portfolios.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.